IMAX Corporation Announces Full Exercise of Over-allotment Option
Posted on: Thursday, 25 June 2009, 06:30 CDT
Closing of the over-allotment option is expected to occur on or about
IMAX intends to use the net proceeds from the offering for the repayment of debt, including a portion of its 9 5/8% Senior Notes due
Roth Capital Partners, LLC acted as the underwriter for the offering.
The common stock was offered pursuant to an effective registration statement filed with the Securities and Exchange Commission. Offers and sales of the common stock will be made only by the related prospectus and prospectus supplement. Copies of the prospectus and prospectus supplement relating to this offering may be obtained from Roth Capital Partners by e-mail to rothecm@roth.com, by fax to (949) 720-7227 or by mail to 24 Corporate Plaza Drive,
About IMAX Corporation
IMAX Corporation is one of the world's leading entertainment technology companies, specializing in immersive motion picture technologies. The worldwide IMAX network is among the most important and successful theatrical distribution platforms for major event
This press release contains forward looking statements that are based on management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, general economic, market or business conditions, including the length and severity of the current economic downturn, the opportunities that may be presented to and pursued by the Company, the performance of IMAX DMR films, conditions in the in-home and out-of home entertainment industries, the signing of theatre system agreements, changes and developments in the commercial exhibition industry, the failure to convert theatre system backlog into revenue, investments and operations in foreign jurisdictions, foreign currency fluctuations and the Company's prior restatements and the related litigation and ongoing inquiries by the SEC and the OSC. These factors and other risks and uncertainties are discussed in the Company's most recent Annual Report on Form 10-K and most recent Quarterly Reports on Form 10-Q.
SOURCE IMAX Corporation
Source: PR Newswire
Related Articles
- Select Medical Holdings Corporation Successfully Completes Initial Public Offering of Common Stock
- SXC Health Solutions announces pricing of upsized public offering of common shares
- Mariner Energy Prices Public Offerings of Common Stock and Senior Notes
- Pan American silver closes US$103 million public offering of common shares
- Evergreen Solar Prices Public Offering of Common Stock
- Sunoco Logistics Partners L.P. Announces Concurrent Public Offering of Common Units and Senior Notes
- Kayne Anderson MLP Investment Company Prices Secondary Public Offering of Common Stock at $27.00 Per Share
- Sunoco Logistics Partners L.P. Announces Public Offering of Common Units
- Tortoise Energy Capital Corporation Announces Closing of Underwriters' Over-Allotment Option
- Xyratex Ltd Announces Pricing of Its Initial Public Offering of Common Stock
User Comments (0)

RSS Feeds